Yuki Eshita Selected Research

Yuki Eshita Research Topics

4	Dengue (Dengue Fever) 10/2020 - 01/2003
4	Infections 10/2020 - 01/2003
4	Neoplasms (Cancer) 12/2018 - 01/2014
2	Melanoma (Melanoma, Malignant) 12/2018 - 02/2015
2	Neoplasm Metastasis (Metastasis) 12/2018 - 02/2015
2	Malaria 04/2017 - 09/2014
1	Flavivirus Infections 08/2019
1	Autoimmune Diseases (Autoimmune Disease) 02/2019
1	Colitis 02/2019
1	Dysbiosis 02/2019
1	Lymphatic Metastasis 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Carcinogenesis 12/2018
1	Sialadenitis 01/2018
1	Zika Virus Infection 10/2017
1	Communicable Diseases (Infectious Diseases) 10/2017
1	Hepatitis C 10/2017
1	Viremia 10/2017
1	Gnathostomiasis 07/2011
1	Lymphangioma (Cavernous Lymphangioma) 09/2010
1	Severe Dengue 12/2007
1	Japanese Encephalitis 01/2005

2	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2011
2	RNA (Ribonucleic Acid)IBA 08/2019 - 09/2014
2	CytokinesIBA 02/2019 - 02/2015
2	Viral RNAIBA 10/2017 - 12/2007
1	Neutralizing AntibodiesIBA 08/2019
1	Simvastatin (Zocor)FDA LinkGeneric 12/2018
1	CholesterolIBA 12/2018
1	Chemokine ReceptorsIBA 01/2018
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018
1	ChemokinesIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 10/2017
1	InterferonsIBA 10/2017
1	Ribavirin (Virazole)FDA LinkGeneric 10/2017
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2017
1	Antimalarials (Antimalarial Agents)IBA 04/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2015
1	DEAE-Dextran (Pulsar)IBA 02/2015
1	2',3'-dideoxy-5-methylcytidineIBA 02/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015
1	pectenotoxin-4IBA 02/2015
1	VaccinesIBA 03/2014
1	EnzymesIBA 01/2014
1	incomplete Freund's adjuvantIBA 09/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2010
1	Complementary DNA (cDNA)IBA 01/2005
1	TemefosIBA 01/2003

1	Subcutaneous Injections 12/2018
1	Therapeutics 10/2017